VY

Venkatakrishnareddy Yerramreddy

AP Arrien Pharmaceuticals: 9 patents #2 of 8Top 25%
Overall (All Time): #563,480 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10682358 Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis Hariprasad Vankayalapati 2020-06-16
10172866 Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis Hariprasad Vankayalapati 2019-01-08
9951062 Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors Hariprasad Vankayalapati, Venu Babu Ganipisetty, Sureshkumar Talluri, Rajendra P. Appalaneni 2018-04-24
9890153 Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors Hariprasad Vankayalapati, Venu Babu Ganipisetty, Sureshkumar Talluri, Rajendra P. Appalaneni 2018-02-13
9834551 Substituted pyrrolo[2,3-b]pyrazines and substituted pyrazolo[3,4-b]pyridines as ITK and JAK kinase inhibitors Hariprasad Vankayalapati, Paramareddy Gangireddy, Rajendra P. Appalaneni 2017-12-05
9446047 Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis Hariprasad Vankayalapati 2016-09-20
9359315 Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis Hariprasad Vankayalapati 2016-06-07
9260426 Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors Hariprasad Vankayalapati, Venu Babu Ganipisetty, Sureshkumar Talluri, Rajendra P. Appalaneni 2016-02-16
9206188 Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors Hariprasad Vankayalapati, Paramareddy Gangireddy, Rajendra P. Appalaneni 2015-12-08